Mission

We are committed to advancing the field of medicine through research and development of complex generic peptides and synthetic biology to create innovative, safe, and affordable bio-generic drugs and advanced therapeutics.

Vision

To be a global leader in yeast-based drug development, advancing healthcare through cutting-edge research and development.

logo

Our Team

P.V.S.N. Raju

P.V.S.N. Raju

Chairman

Akhilesh Raju

Akhilesh Raju

CEO

T. Devi Kalyan

T. Devi Kalyan

COO

What we do

Developing Cutting-Edge Therapeutics and Solutions with Biology

01

Where cutting-edge science meets innovative technology, our team of experts are dedicated to revolutionizing the healthcare industry by harnessing the power of saccharomyces cerevisiae. Our expertise in complex generic peptides and synthetic biology enables us to develop advanced bio-generic drugs like Liraglutide and Semaglutide. These innovative therapeutics have a significant impact on patients suffering from diabetes, obesity, and cardiovascular diseases.

logo

02

By harnessing the power of fermentation, we are able to create probiotics that are rich in beneficial bacteria and easily digestible.Using synthetic biology, we can customize these probiotics to address specific health concerns, from gut dysbiosis to immune system dysfunction.

logo

03

The forefront of sustainable nutrition - plant-based ingredients created through fermentation and synthetic biology! Our team of experts is dedicated to harnessing the power of nature to develop high-quality, plant-based ingredients that are both delicious and eco-friendly.

logo

Our Pipeline

Liraglutide

API Sample: Ready for shipment

Technology: Saccharomyces Cerevisiae

Stage: Pre - Clinical Testing

Semaglutide

API Sample: Q3 2023

Technology: Saccharomyces Cerevisiae

Stage: Validation Batch Assessment

Glucagon

API Sample: Q1 2024

Technology: Saccharomyces Cerevisiae

Stage: Validation Batch Assessment

Coenzyme Q10

API Sample: Q4 2024

Technology: Saccharomyces Cerevisiae

Stage: Process optimisation

Beta Carotene

Sample for testing: Q4 2024

Technology: Saccharomyces Cerevisiae

Stage: POC Completed

Saffron

Sample for testing: Q4 2024

Technology: Saccharomyces Cerevisiae

Stage: Process optimisation

Stevia

Sample for testing: Q4 2024

Technology: Saccharomyces Cerevisiae

Stage: Validation Batch Assessment

logo

How we do it?

We identify,
We re-engineer,
We manufacture.

We’re making biology easier to scale up.
Re-engineering living cells is complex but not impossible!
We believe that fermentation is the best manufacturing technology on the planet.

Amogen's Fermentation-Based Complex Peptide Manufacturing Facility

01

India’s Largest Peptide Facility

Amogen's Hyderabad facility is the single largest fermentation-based peptide manufacturing plant in India.

02

Cutting-Edge Fermentation Technology

The facility utilises state-of-the-art fermentation processes to synthesise a diverse range of peptides with high efficiency and precision.

03

Wide Array of Peptide Products

Amogen's Hyderabad plant is capable of producing numerous peptide-based products, including therapeutic complex generic peptides.

04

High Capacity Production

The Hyderabad facility boasts a massive production capacity, making Amogen a leading global supplier of peptide products..

05

Strict Quality Control Measures

Amogen adheres to rigorous quality control protocols, ensuring that all peptide products manufactured meet the highest international standards.

06

Support for Global Clients

Amogen's facility caters to the growing demand for peptide products worldwide, providing valuable support for pharmaceutical, biotech, and cosmetic industries.

07

Compliance with Regulatory Standards

The Hyderabad facility adheres to international regulatory requirements such as FDA, EMA, and GMP standards, ensuring the highest level of safety and quality

logo